Guggenheim Capital’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2
| Closed | -$5K | – | 2590 |
|
|
2018
Q1 | $5K | Hold |
2
| – | – | ﹤0.01% | 2776 |
|
|
2017
Q4 | $7K | Hold |
2
| – | – | ﹤0.01% | 2695 |
|
|
2017
Q3 | $13K | Hold |
2
| – | – | ﹤0.01% | 2770 |
|
|
2017
Q2 | $8K | Hold |
2
| – | – | ﹤0.01% | 2814 |
|
|
2017
Q1 | $10K | Hold |
2
| – | – | ﹤0.01% | 2817 |
|
|
2016
Q4 | $13K | Hold |
2
| – | – | ﹤0.01% | 2872 |
|
|
2016
Q3 | $28K | Hold |
2
| – | – | ﹤0.01% | 2795 |
|
|
2016
Q2 | $30K | Hold |
2
| – | – | ﹤0.01% | 2790 |
|
|
2016
Q1 | $34K | Buy |
2
+1
| +100% | +$17K | ﹤0.01% | 2805 |
|
|
2015
Q4 | $29K | Hold |
1
| – | – | ﹤0.01% | 2904 |
|
|
2015
Q3 | $29K | Buy |
+1
| New | +$29K | ﹤0.01% | 2876 |
|
|
2014
Q3 | – | Sell |
-2
| Closed | -$25K | – | 3050 |
|
|
2014
Q2 | $25K | Hold |
2
| – | – | ﹤0.01% | 3102 |
|
|
2014
Q1 | $42K | Buy |
2
+1
| +100% | +$21K | ﹤0.01% | 3099 |
|
|
2013
Q4 | $16K | Buy |
+1
| New | +$16K | ﹤0.01% | 3084 |
|